期刊文献+

Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development 被引量:4

Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development
原文传递
导出
摘要 Transforming growth factor-β(TGF-β) signaling regulates cell proliferation, differentiation, migration and death, and plays a critical role in embryogenesis and tissue homeostasis. Its deregulation results in various diseases including tumor formation.Receptor tyrosine kinases(RTKs), such as epidermal growth factor receptor(EGFR), fibroblast growth factor receptor(FGFR),vascular endothelial growth factor receptor(VEGFR) and platelet-derived growth factor receptor(PDGFR), also play key roles in the development and progression of many types of tumors. It has been realized that TGF-β signaling and RTK pathways interact with each other and their interplay is important for cancer development. They are mutually regulated and cooperatively modulate cell survival and migration, epithelial-mesenchymal transition, and tumor microenvironment to accelerate tumorigenesis and tumor metastasis. RTKs can modulate Smad-dependent transcription or cooperate with TGF-β to potentiate its oncogenic activity,while TGF-β signaling can in turn control RTK signaling by regulating their activities or expression. This review summarizes current understandings of the interplay between TGF-β signaling and RTKs and its influence on tumor development. Transforming growth factor-β(TGF-β) signaling regulates cell proliferation, differentiation, migration and death, and plays a critical role in embryogenesis and tissue homeostasis. Its deregulation results in various diseases including tumor formation.Receptor tyrosine kinases(RTKs), such as epidermal growth factor receptor(EGFR), fibroblast growth factor receptor(FGFR),vascular endothelial growth factor receptor(VEGFR) and platelet-derived growth factor receptor(PDGFR), also play key roles in the development and progression of many types of tumors. It has been realized that TGF-β signaling and RTK pathways interact with each other and their interplay is important for cancer development. They are mutually regulated and cooperatively modulate cell survival and migration, epithelial-mesenchymal transition, and tumor microenvironment to accelerate tumorigenesis and tumor metastasis. RTKs can modulate Smad-dependent transcription or cooperate with TGF-β to potentiate its oncogenic activity,while TGF-β signaling can in turn control RTK signaling by regulating their activities or expression. This review summarizes current understandings of the interplay between TGF-β signaling and RTKs and its influence on tumor development.
出处 《Science China(Life Sciences)》 SCIE CAS CSCD 2017年第10期1133-1141,共9页 中国科学(生命科学英文版)
关键词 TGF-Β receptor tyrosine kinase CROSSTALK tumor development TGF-β receptor tyrosine kinase crosstalk tumor development
  • 相关文献

参考文献3

二级参考文献29

  • 1[1]Schechter AL, Hung MC, Vaidyanathan L, et al. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 1985; 4717:976-78.
  • 2[2]Bacus SS, Ruby SG, Weinberg DS, et al. HER-2/neu oncogene expression and proliferation in breast cancers. Am J Pathol 1990;137:103-11.
  • 3[3]Berchuck A, Kamel A, Whitaker R. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990; 50:4087-91.
  • 4[4]Borg A, Tandon AK, Sigurdsson H. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 1990; 50:4332-7.
  • 5[5]Zhou BP, Hu MC, Miller SA, et al. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem 2000; 275:8027-31.
  • 6[6]Sabbatim P, McCormick F. Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcrptionally dependen apoptosis. J Biol Chem 1999; 274:24263-69.
  • 7[7]Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351:453-6.
  • 8[8]Hollstein M, Sidransky D, Vogelstein B Harris CC. p53 mutations in human cancers. Science 1991, 253:49-53.
  • 9[9]Woods DB, Vousden KH. Regulation of p53 function. Exp Cell Res 2001; 264:56-66.
  • 10[10]Zheng L, Ren JQ, Chen Q, et al. Preparation of Anti-HER2/neu monoclonal antibody and its inhibiting ablility on the growth of breast carcinoma cells. Fudan Univ J Med Sci 2003; 30:151-3.

共引文献100

同被引文献21

引证文献4

二级引证文献211

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部